Evidence map›Paper›PMID 34362172›Full record

ArticleJournal of clinical medicine2021

Decrease in Incidence Rate of Hospitalizations Due to AIDS-Defining Conditions but Not to Non-AIDS Conditions in PLWHIV on cART in 2008-2018 in Italy.

Silvia Nozza, Laura Timelli, Annalisa Saracino, Nicola Gianotti, Claudia Lazzaretti, Alessandro Tavelli, Massimo Puoti, Sergio Lo Caputo, Andrea Antinori, Antonella d'Arminio Monforte and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Role of the pharmacist caring for people at risk of or living with HIV in Canada.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Silvia NozzaDepartment of Infectious Diseases, San Raffaele Scientific Institute, 20127 Milano, Italy.
Laura TimelliNational Institute for Infectious Diseases L. Spallanzani, IRCCS, 00077 Rome, Italy.
Annalisa SaracinoInfectious Diseases Department, Università degli Studi di Bari, 70126 Bari, Italy.
Nicola GianottiDepartment of Infectious Diseases, San Raffaele Scientific Institute, 20127 Milano, Italy.
Claudia LazzarettiCilinic of Infectious Diseases, Arcispedale Santa Maria Nuova, 42123 Reggio Emilia, Italy.
Alessandro TavelliICONA Foundation, 20126 Milano, Italy.
Massimo PuotiDepartment of Infectious Diseases, ASST Grande Ospedale Metropolitano Niguarda, 20126 Milano, Italy.
Sergio Lo CaputoInfectious Diseaes Department, University of Foggia, 71122 Foggia, Italy.
Andrea AntinoriNational Institute for Infectious Diseases L. Spallanzani, IRCCS, 00077 Rome, Italy.
Antonella d'Arminio MonforteDepartment of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, 20126 Milano, Italy.
Cristina MussiniCilinic of Infectious Diseases, Arcispedale Santa Maria Nuova, 42123 Reggio Emilia, Italy.
Enrico GirardiNational Institute for Infectious Diseases L. Spallanzani, IRCCS, 00077 Rome, Italy.ORCID 0000-0001-8182-5896
On Behalf Of Icona Foundation Study Group
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITOspedale Santa Maria · ITSan Raffaele University of Rome · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITUniversity of Bari Aldo Moro · ITUniversity of Foggia · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to describe the change in the incidence and causes of hospitalization between 2008 and 2018 among persons living with HIV (PLWHIV) who started antiretroviral therapy (ART) from 2008 onwards in Italy.

methodsWe included participants in the ICONA (Italian Cohort Naïve Antiretrovirals) cohort who started ART in 2008. All the hospitalizations occurring during the first 30 days from the start of ART were excluded. Hospitalizations were classified as due to: AIDS-defining conditions (ADC), non-ADC infections and non-infections/non-ADC (i.e., cardiovascular, pulmonary, renal-genitourinary, cancers, gastrointestinal-liver, psychiatric and other diseases). Comparisons of rates across time were assessed using Poisson regression. The Poisson multivariable model evaluated risk factors for hospitalizations, including both demographic and clinical characteristics.

resultsA total of 9524 PLWHIV were included; 6.8% were drug users, 48.9% men-who-have sex with men (MSM), 39.6% heterosexual contacts; 80.8% were males, 42.3% smokers, 16.6% coinfected with HCV and 6.8% with HBV (HBsAg-positive). During 36,157 person-years of follow-up (PYFU), there were 1058 hospitalizations in 747 (7.8%) persons; they had HIV-RNA >50 copies mL in 34.9% and CD4 < 200/mmc in 27%. Causes of hospitalization were 23% ADC, 22% non-ADC infections, 55% non-infections/non-ADC (11% cancers; 9% gastrointestinal-liver; 6% cardiovascular; 5% renal-genitourinary; 5% psychiatric; 4% pulmonary; 15% other). Over the study period, the incidence rate (IR) decreased significantly (from 5.8 per 100 PYFU in 2008-2011 to 2.21 per 100 PYFU in 2016-2018). Age > 50 years, intravenous drug use (IDU), family history of cardiovascular disease, HIV-RNA > 50, CD4 < 200, were associated with a higher hospitalization risk.

conclusionsIn our population of PLWHIV, the rate of hospitalization decreased over time.

Indexed as

hospitalizationsnon-AIDS defining conditionsPLWHIV

Identifiers

PMID34362172
PMCPMC8347382
OpenAlexW3192283073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.